GB
The startup has developed a recombinant protein production technology that removes the origin of replication from bacterial chromosomes, allowing cells to remain metabolically active without dividing. This approach enables users to decouple protein production from cellular growth, enhancing yield and efficiency in biomanufacturing processes.
Updated 18 months ago
Funding
$470K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a recombinant protein production technology that removes the origin of replication from bacterial chromosomes, allowing cells to remain metabolically active without dividing. This approach enables users to decouple protein production from cellular growth, enhancing yield and efficiency in biomanufacturing processes.